FMWA
Forvis Mazars Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.99M | Sell |
7,383
-241
| -3% | -$97.7K | 0.06% | 122 |
|
|
2025
Q1 | $3.79M | Buy |
7,624
+452
| +6% | +$225K | 0.09% | 106 |
|
|
2024
Q4 | $3.73M | Sell |
7,172
-237
| -3% | -$123K | 0.09% | 109 |
|
|
2024
Q3 | $4.58M | Buy |
7,409
+271
| +4% | +$168K | 0.11% | 97 |
|
|
2024
Q2 | $3.95M | Sell |
7,138
-141
| -2% | -$78K | 0.1% | 107 |
|
|
2024
Q1 | $4.23M | Buy |
7,279
+760
| +12% | +$442K | 0.11% | 101 |
|
|
2023
Q4 | $3.46M | Buy |
6,519
+67
| +1% | +$35.6K | 0.1% | 109 |
|
|
2023
Q3 | $3.27M | Sell |
6,452
-2,188
| -25% | -$1.11M | 0.1% | 109 |
|
|
2023
Q2 | $4.51M | Buy |
8,640
+1,978
| +30% | +$1.03M | 0.13% | 101 |
|
|
2023
Q1 | $3.84M | Buy |
6,662
+543
| +9% | +$313K | 0.13% | 101 |
|
|
2022
Q4 | $3.37M | Buy |
6,119
+121
| +2% | +$66.6K | 0.12% | 104 |
|
|
2022
Q3 | $3.04M | Buy |
5,998
+219
| +4% | +$111K | 0.12% | 102 |
|
|
2022
Q2 | $3.14M | Buy |
5,779
+256
| +5% | +$139K | 0.13% | 91 |
|
|
2022
Q1 | $3.26M | Buy |
5,523
+803
| +17% | +$474K | 0.14% | 79 |
|
|
2021
Q4 | $3.15M | Buy |
4,720
+146
| +3% | +$97.4K | 0.13% | 79 |
|
|
2021
Q3 | $2.61M | Buy |
4,574
+400
| +10% | +$229K | 0.12% | 82 |
|
|
2021
Q2 | $2.11M | Sell |
4,174
-149
| -3% | -$75.2K | 0.1% | 92 |
|
|
2021
Q1 | $1.97M | Sell |
4,323
-2,162
| -33% | -$987K | 0.1% | 94 |
|
|
2020
Q4 | $3.02M | Buy |
6,485
+1,039
| +19% | +$484K | 0.15% | 75 |
|
|
2020
Q3 | $2.41M | Buy |
5,446
+195
| +4% | +$86.1K | 0.14% | 77 |
|
|
2020
Q2 | $1.9M | Buy |
5,251
+670
| +15% | +$243K | 0.12% | 87 |
|
|
2020
Q1 | $1.3M | Buy |
4,581
+170
| +4% | +$48.2K | 0.11% | 96 |
|
|
2019
Q4 | $1.43M | Buy |
4,411
+138
| +3% | +$44.8K | 0.1% | 103 |
|
|
2019
Q3 | $1.25M | Buy |
4,273
+53
| +1% | +$15.4K | 0.1% | 106 |
|
|
2019
Q2 | $1.24M | Buy |
4,220
+1,676
| +66% | +$492K | 0.1% | 104 |
|
|
2019
Q1 | $696K | Buy |
2,544
+148
| +6% | +$40.5K | 0.06% | 130 |
|
|
2018
Q4 | $536K | Buy |
2,396
+54
| +2% | +$12.1K | 0.05% | 132 |
|
|
2018
Q3 | $572K | Buy |
2,342
+1,272
| +119% | +$311K | 0.05% | 134 |
|
|
2018
Q2 | $222K | Sell |
1,070
-583
| -35% | -$121K | 0.02% | 219 |
|
|
2018
Q1 | $341K | Buy |
1,653
+568
| +52% | +$117K | 0.03% | 185 |
|
|
2017
Q4 | $206K | Sell |
1,085
-91
| -8% | -$17.3K | 0.02% | 232 |
|
|
2017
Q3 | $222K | Sell |
1,176
-87
| -7% | -$16.4K | 0.02% | 210 |
|
|
2017
Q2 | $220K | Buy |
+1,263
| New | +$220K | 0.02% | 209 |
|
|
2016
Q1 | – | Sell |
-1,444
| Closed | -$205K | – | 204 |
|
|
2015
Q4 | $205K | Buy |
+1,444
| New | +$205K | 0.03% | 182 |
|